AKL Technologies, Ltd. was formed in April, 2001 to further develop and commercialize discoveries by Dr. Nicholas Larkins initially pertaining to a product known as 'AKL1.' AKL believes AKL1 can be used in the treatment of asthma, COPD and other respiratory diseases.
In 2007, AKL Technologies, Ltd, was taken over by and is now a subsidiary of AKL International, Ltd., a company incorporated in the BVI. Based on the success of AKL1, the Company has recently expanded its scope to develop additional drug candidates.
Milestones
· Multiple patents filed on multiple discoveries in over 25 countries.
· Granted patents in many countries including US, Australia and EU.
· In-Vitro testing proving synergistic qualities of AKL1.
· Successful completion of a double blinded UK DDX trial of AKL1.
· Successful completion of an efficacy trial of AKL4 (aka APPA).
Key Personnel - AKL International, Ltd.: Advisory Board
Dr. Nicholas Larkins, BVSc DSc MRCVS
Career veterinarian and expert in nutritional medicine. Served as a research scientist and consultant for many companies such as Agrilab, Natural Animal Feeds, Probiotics International, Medi-Equus, Nutritional Laboratories, Phytomedicine, S.I.A.L., Girovet, and N Health (PawCare).
David Sharples
Founder and CEO Public Works Corp., Miami-based software solutions and internet development company founded in 1996.
Rodolfo Beeck MBA
President of Creek Investments Management, LLC, an investments management firm.
Key Personnel - AKL Technologies, Ltd.: Advisory Board
Lord Grade, CBE
Non Executive Chairman of Pinewood and Shepperton Studios, Ocado Ltd and James Grant Group. High profile career in the broadcast media as a top executive at the BBC, Channel 4 Television, Embassy Television, London Weekend Television.
Professor David Price, B.A. M.B B.Chir M.A. D.R.C.O.G, FP Cert MRCGP – Chief Science Officer
General Practice Airways Group Professor of Primary Care Respiratory Medicine, University of Aberdeen; Visiting Fellow, University of East Anglia; General Practitioner, Norfolk; Lead GP for SAND a NHS Culyer research consortium in East Anglia. Research interests include primary care respiratory disease including asthma, smoking cessation, COPD, rhinitis, respiratory infections and lung cancer. Understanding clinical effectiveness of management and therapeutic interventions.
Richard Cleeve
Founder and Managing Director Natural Animal Feeds ("N.A.F.") founded in 1983, Europe’s leading brand of nutriceuticals for the equine, small animal and human markets.